Cellect Biotechnology Ltd (APOP):製薬・医療:M&Aディール及び事業提携情報

◆英語タイトル:Cellect Biotechnology Ltd (APOP) - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA904C8153
◆発行会社(調査会社):GlobalData
◆発行日:2018年10月
◆ページ数:49
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:イスラエル
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Cellect Biotechnology Ltd (Cellect Biotechnology) formerly Cellect Biomed Ltd is a clinical stage biotechnology company which develops stem cell selection technologies for the production of stem cells based products in the field of regenerative medicine. The company’s technology platform is developing ApoGraft solutions which provides functional selection of stem and progenitor cells through an apoptotic process with focus on hematopoietic cells field. It is developing ApoTainer selection kit, a off-the-shelf medical device product for use in bone marrow transplantation, immune disorders and organ transplantations. The company offers licensing opportunities to pharmaceutical companies, medical research centers, academies and hospitals with the tools to rapidly isolate stem cells and allow stem cell related treatments and procedures. Cellect Biotechnology is headquartered in Kfar Saba, Israel.

Cellect Biotechnology Ltd (APOP) – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 5
List of Figures 5
Cellect Biotechnology Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 6
Cellect Biotechnology Ltd, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 7
Cellect Biotechnology Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 8
Cellect Biotechnology Ltd, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 9
Cellect Biotechnology Ltd, Medical Devices Deals, 2012 to YTD 2018 10
Cellect Biotechnology Ltd, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 11
Cellect Biotechnology Ltd, Pharmaceuticals & Healthcare, Deal Details 12
Partnerships 12
Cellect Biotech Enters into Agreement with Hadasit Medical Research Services & Development 12
Accellta Enters into Agreement with Cellect Biomed 13
Equity Offering 14
Cellect Biotechnology to Raise USD4 Million in Private Placement of American Depositary Shares 14
Cellect Biotech Raises USD4.3 Million in Private Placement of American Depositary Shares 15
Cellect Biotechnology Raises USD8.4 Million in IPO of ADS 17
Cellect Biotech Raises Funds through Private Placement of Shares upon Exercise of Warrants 19
Cellect Biotech Raises Funds through Private Placement of Shares 20
Cellect Biotech Raises USD4.3 Million in Private Placement of Shares 21
Cellect Biotech to Raise USD1 Million in Private Placement of Shares 22
Cellect Biotechnology Ltd – Key Competitors 23
Cellect Biotechnology Ltd – Key Employees 24
Cellect Biotechnology Ltd – Locations And Subsidiaries 25
Head Office 25
Recent Developments 26
Financial Announcements 26
May 17, 2018: Cellect Biotechnology Provides Corporate Update and Reports First Quarter 2018 Financial Results 26
Mar 19, 2018: Cellect Biotechnology Provides Corporate Update and Reports Fourth Quarter and Full Year 2017 Financial Results 27
Nov 22, 2017: Cellect Biotechnology Provides Corporate Update and Reports Third Quarter 2017 Financial Results 29
Aug 21, 2017: Cellect Biotechnology Provides Corporate Update and Reports Second Quarter 2017 Financial Results 30
May 29, 2017: Cellect Biotechnology Provides Corporate Update and Reports First Quarter 2017 Financial Results 31
Mar 23, 2017: Cellect Biotechnology Provides Corporate Update and Reports Fourth Quarter and Full Year 2016 Financial Results 32
Corporate Communications 34
May 10, 2018: Former GE Healthcare Executive to Join Cellect as Chief Business Officer 34
Oct 19, 2017: Cellect Appoints Dr. Ronit Bakimer-Kleiner as Chief Development Officer 35
Jun 09, 2017: Cellect is Moving to Trade Exclusively on the NASDAQ 36
May 23, 2017: David Braun, Head of Merck Device Business, Joins Cellect’s Advisory Board 37
Mar 02, 2017: Michael Berelowitz MD., Former Head, Clinical Development and Medical Affairs, Pfizer Specialty Care Business Unit Joins Cellect’s Board of Directors 38
Feb 23, 2017: World-Renowned Stem Cell Transplantation Expert joins Cellect’s Advisory Board 39
Feb 14, 2017: Dual-Listed Cellect to Voluntarily File for Delisting from Tel Aviv Stock Exchange 40
Jan 30, 2017: Dr. Yaron Pereg Appointed as New Chief Development Officer 41
Jan 03, 2017: Cellect Announces Appointment of Eyal Leibovitz, Experienced Life Sciences Industry and Financial Executive, as Chief Financial Officer 42
Product News 43
03/27/2017: Cellect Announces Successful First Cancer Patient Stem Cell Transplant 43
02/21/2017: Cellect Announces Positive Clinical Trial Results 44
02/08/2017: First Cancer Patient Treated In Phase I/II Trial of ApoGraft 45
Product Approvals 46
Sep 05, 2017: FDA Grants Orphan Drug Status to Cellect’s ApoGraft for Acute GvHD and Chronic GvHD 46
May 03, 2017: Cellect Gets Green Light From FDA For ApoGraft IND Submission in the U.S. 47
Other Significant Developments 48
Apr 09, 2018: Cellect Announces a Major Milestone for Enabling Stem Cells Production 48
Appendix 49
Methodology 49
About GlobalData 49
Contact Us 49
Disclaimer 49

List of Tables
Cellect Biotechnology Ltd, Pharmaceuticals & Healthcare, Key Facts, 2016 2
Cellect Biotechnology Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 6
Cellect Biotechnology Ltd, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 7
Cellect Biotechnology Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 8
Cellect Biotechnology Ltd, Deals By Therapy Area, 2012 to YTD 2018 9
Cellect Biotechnology Ltd, Medical Devices Deals, 2012 to YTD 2018 10
Cellect Biotechnology Ltd, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 11
Cellect Biotech Enters into Agreement with Hadasit Medical Research Services & Development 12
Accellta Enters into Agreement with Cellect Biomed 13
Cellect Biotechnology to Raise USD4 Million in Private Placement of American Depositary Shares 14
Cellect Biotech Raises USD4.3 Million in Private Placement of American Depositary Shares 15
Cellect Biotechnology Raises USD8.4 Million in IPO of ADS 17
Cellect Biotech Raises Funds through Private Placement of Shares upon Exercise of Warrants 19
Cellect Biotech Raises Funds through Private Placement of Shares 20
Cellect Biotech Raises USD4.3 Million in Private Placement of Shares 21
Cellect Biotech to Raise USD1 Million in Private Placement of Shares 22
Cellect Biotechnology Ltd, Key Competitors 23
Cellect Biotechnology Ltd, Key Employees 24

List of Figures
Cellect Biotechnology Ltd, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
Cellect Biotechnology Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
Cellect Biotechnology Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
Cellect Biotechnology Ltd, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
Cellect Biotechnology Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 6
Cellect Biotechnology Ltd, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 7
Cellect Biotechnology Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 8
Cellect Biotechnology Ltd, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 9
Cellect Biotechnology Ltd, Medical Devices Deals, 2012 to YTD 2018 10

★海外企業調査レポート[Cellect Biotechnology Ltd (APOP):製薬・医療:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • InteRNA Technologies BV-製薬・医療分野:企業M&A・提携分析
    Summary InteRNA Technologies BV (InteRNA) is a biotechnology company that specializes in the development of RNA therapeutics for the treatment of cancer. The company develops technologies in biomedical research translating miRNA sequence fields. Its drug development programs focuses on developing mi …
  • Sihuan Pharmaceutical Holdings Group Ltd (460):製薬・医療:M&Aディール及び事業提携情報
    Summary Sihuan Pharmaceutical Holdings Group Ltd (Sihuan Pharmaceutical) is a pharmaceutical company that develops, manufactures and markets prescription drugs. The company offers products in the therapeutic areas of cardio-cerebral vascular system, central nervous system, metabolism, oncology and a …
  • Thermax Ltd (THERMAX):企業の財務・戦略的SWOT分析
    Thermax Ltd (THERMAX) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and …
  • Can-Fite BioPharma Ltd (CANF):企業の財務・戦略的SWOT分析
    Summary Can-Fite BioPharma Ltd (Can-Fite) is a clinical stage drug development Company that strives to develop small molecule drugs for the treatment of cancer and inflammatory diseases. The company’s pipeline products which are in phase II and III clinical development stage includes CF101, for rheu …
  • Boursorama Sa
    Boursorama Sa - Strategy, SWOT and Corporate Finance Report Summary Boursorama Sa - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate …
  • MRI Interventions Inc (MRIC):企業の製品パイプライン分析2018
    Summary MRI Interventions Inc (MRI Interventions) is a medical equipment company that develops and commercializes platforms for performing invasive surgical procedures. The company’s products include systems used for performing invasive surgeries on brain and heart. Its products are used for treatin …
  • Halliburton Co (HAL)-石油・ガス分野:企業M&A・提携分析
    Summary Halliburton Company (Halliburton) is an oilfield services company. The company serves the upstream oil and gas industry throughout the lifecycle of the reservoir, from identifying hydrocarbons and managing geological data, to drilling and formation evaluation, well construction and completio …
  • Hubbell Incorporated:企業の戦略・SWOT・財務情報
    Hubbell Incorporated - Strategy, SWOT and Corporate Finance Report Summary Hubbell Incorporated - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings …
  • Campine NV (CAMB):企業の財務・戦略的SWOT分析
    Campine NV (CAMB) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the …
  • Parity Group plc (PTY):企業の財務・戦略的SWOT分析
    Summary Parity Group plc (Parity) is a technology company that offers professional recruitment, IT solutions and consultancy services. The company’s technology solutions include business intelligence, database analytics and development; IT consulting and application management support.The company pr …
  • Airgas Inc:企業の戦略的SWOT分析
    Airgas Inc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services. T …
  • Creganna Medical:企業の戦略的SWOT分析
    Creganna Medical - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and servi …
  • TPF SA:企業の戦略的SWOT分析
    TPF SA - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services. This …
  • Regulus Therapeutics Inc (RGLS):企業の財務・戦略的SWOT分析
    Summary Regulus Therapeutics Inc (Regulus Therapeutics) is a biopharmaceutical company that discovers and develops microRNA based therapeutics. The company provides single stranded oligonucleotides, which are chemically synthesized chains of nucleotides that are mirror images of specific target micr …
  • Sterling Bank Plc:企業の戦略・SWOT・財務分析
    Sterling Bank Plc - Strategy, SWOT and Corporate Finance Report Summary Sterling Bank Plc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and c …
  • CryoPort Inc (CYRX):製薬・医療:M&Aディール及び事業提携情報
    Summary Cryoport, Inc. (Cryoport) is a provider of cold chain logistics solutions for temperature-sensitive biological materials to the life science industries. It offers liquid nitrogen dry vapor shippers with advanced logistics management platform called Cryoportal, which provides credentials rela …
  • Siluria Technologies Inc:石油・ガス:M&Aディール及び事業提携情報
    Summary Siluria Technologies Inc (Siluria) engaged in producing fuels and chemicals from natural gas and low value byproducts. Its products include modus - olefins to gasoline, and gemini - natural gas to ethylene. The company also involved in catalytic process to convert natural gas into liquid fue …
  • F. Hoffmann-La Roche Ltd (ROG):企業の財務・戦略的SWOT分析
    F. Hoffmann-La Roche Ltd (ROG) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakn …
  • AmeriGas Partners LP (APU):企業の財務・戦略的SWOT分析
    Summary AmeriGas Partners LP (AmeriGas) is an oil and gas company that distributes propane liquid. The company supply propane for residential and business applications. AmeriGas propane is used in residential applications such as propane home heating, propane water heating, and propane for drying cl …
  • Intellipharmaceutics International Inc (IPCI):企業の財務・戦略的SWOT分析
    Intellipharmaceutics International Inc (IPCI) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key stre …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆